Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Biofrontera (BFRIW) Non-Current Receivables (2021 - 2022)

Biofrontera has reported Non-Current Receivables over the past 2 years, most recently at $2.8 million for Q4 2022.

  • Quarterly results put Non-Current Receivables at $2.8 million for Q4 2022, changed 0.0% from a year ago — trailing twelve months through Dec 2022 was $2.8 million (changed 0.0% YoY), and the annual figure for FY2022 was $2.8 million, changed 0.0%.
  • Non-Current Receivables for Q4 2022 was $2.8 million at Biofrontera, roughly flat from $2.8 million in the prior quarter.
  • Over the last five years, Non-Current Receivables for BFRIW hit a ceiling of $2.8 million in Q4 2021 and a floor of $2.8 million in Q4 2021.